C1s 保护皮肤状癌细胞免受 TRAIL 诱导的亡
Maria Salmela1,2, Liisa Nissinen1,2, Pekka Rappu3
1Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland.
Oncogenesis
|March 6, 2026
概括
补充C1s促进皮肤状细胞癌 (cSCC) 的生长和转移. C1s通过上调DR4受体来保护cSCC细胞免受 TRAIL诱导的亡,这表明C1s是攻击性皮肤癌的治疗标.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 皮肤状细胞癌 (cSCC) 是一种流行转移性皮肤癌,预后不佳.
- 目前针对晚期或转移性cSCC的治疗策略有限,缺乏转移的预测生物标志物.
- 补充蛋白C1s被认为通过调节亡信号传递来促进cSCC生长.
研究的目的:
- 调查C1s在调节cSCC细胞中亡中的机制性作用.
- 为了识别C1s调节的细胞表面蛋白质,参与了细胞亡.
- 探索C1s在攻击性cSCC中的治疗潜力.
主要方法:
- 在C1s沉默cSCC细胞中细胞表面蛋白质的质谱分析.
- 在siRNA-knockdown和CRISPR/Cas9-knockoutcSCC细胞中使用细胞表面生物化和西部斑进行验证.
- 功能性测试评估不同C1s水平的cSCC细胞中的亡耐药性.
主要成果:
- 沉默C1s导致TRAIL受体1 (DR4) 的细胞表面积累增加.
- 降低的C1s水平使cSCC细胞对TRAIL诱导的亡敏感.
- 高C1s水平赋予了对TRAIL诱导的亡的抵抗力,而C1s的枯竭使细胞敏感.
结论:
- 在cSCC中C1s的上调有助于瘤进展,并防止TRAIL诱导的亡.
- C1s调节DR4细胞表面表达,从而影响cSCC中的亡信号传递.
- C1s代表了一个潜在的治疗标和预测性生物标志物,用于攻击性cSCC.
更多相关视频
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
15.6K
11:28Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
9.0K
相关概念视频
The Intrinsic Apoptotic Pathway
9.0K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
Skin Cancer
6.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.4K
The Extrinsic Apoptotic Pathway
9.1K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.1K
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Caspases
14.4K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
14.4K
Clinical Applications of Epidermal Stem Cells
3.4K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K
